Mirexus Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 7

Employees

  • Latest Deal Type
  • M&A

Mirexus General Information

Description

Producer of natural biomaterials intended to commercialize nanotechnology based on polysaccharide nanoparticles. The company's biomaterials can be used in a variety of markets including cosmetics, nutraceutical, and biomedical applications in animal and human health, enabling clients to have a plant-based form of glycogen.

Contact Information

Website
mirexusbiotech.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 574 Hanlon Creek Boulevard
  • Guelph, Ontario N1C 0A1
  • Canada
+1 (519)
Primary Industry
Biotechnology
Acquirer
Mibelle Biochemistry
Vertical(s)
Nanotechnology, TMT, Life Sciences
Corporate Office
  • 574 Hanlon Creek Boulevard
  • Guelph, Ontario N1C 0A1
  • Canada
+1 (519)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mirexus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 15-Feb-2023 Completed Generating Revenue
6. Grant 27-Nov-2017 Completed Generating Revenue
5. Later Stage VC (Series B) 29-Jun-2017 Completed Generating Revenue
4. Later Stage VC (Series A) 08-Oct-2015 Completed Generating Revenue
3. Later Stage VC 13-Mar-2014 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Grant 01-Jan-2014 $1.17M Completed Generating Revenue
To view Mirexus’s complete valuation and funding history, request access »

Mirexus Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Producer of natural biomaterials intended to commercialize nanotechnology based on polysaccharide nanoparticles. The com
Biotechnology
Guelph, Canada
7 As of 2022

Osaka, Japan
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Mirexus Competitors (1)

One of Mirexus’s competitors is Ezaki Glico, a Corporation company based in Osaka, Japan.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ezaki Glico Corporation Osaka, Japan
You’re viewing 1 of 1 competitors. Get the full list »

Mirexus Patents

  • 31

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Mirexus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022140850-A1 Immune- stimulating compounds linked to glycogen-based polysaccharide nanoparticles for sensitizing cancer cells to a chemotherapeutic drug Inactive 28-Dec-2020
WO-2020227810-A1 Immune-stimulating compositions for aquaculture species Inactive 10-May-2019
WO-2020124234-A1 Water soluble mask Inactive 18-Dec-2018
WO-2020037433-A1 Compounds and compositions for potentiation of tlr agonists Inactive 24-Aug-2018
AU-2017260705-A1 Glycogen and phytoglycogen nanoparticles as immunosuppressive compounds, and compositions and methods of use thereof Inactive 04-May-2016 A61K9/14
To view Mirexus’s complete patent history, request access »

Mirexus Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mirexus Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Asahi Kasei Corporate Venture Capital Corporate Venture Capital Minority
Boundless Accelerator Accelerator/Incubator
Goddard Enterprises Corporation Minority
Government of Canada Limited Partner
GreenSky Ventures Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Mirexus Investments (1)

Mirexus’s most recent deal was a Corporate with Veriphy Skincare.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Veriphy Skincare Corporate Personal Products
To view Mirexus’s complete investments history, request access »

Ready to get started?

Request a free trial

Mirexus FAQs

  • When was Mirexus founded?

    Mirexus was founded in 2008.

  • Where is Mirexus headquartered?

    Mirexus is headquartered in Guelph, Canada.

  • What is the size of Mirexus?

    Mirexus has 7 total employees.

  • What industry is Mirexus in?

    Mirexus’s primary industry is Biotechnology.

  • Is Mirexus a private or public company?

    Mirexus is a Private company.

  • What is Mirexus’s current revenue?

    The current revenue for Mirexus is .

  • How much funding has Mirexus raised over time?

    Mirexus has raised $16.1M.

  • Who are Mirexus’s investors?

    Asahi Kasei Corporate Venture Capital, Boundless Accelerator, Goddard Enterprises, Government of Canada, and GreenSky Ventures are 5 of 8 investors who have invested in Mirexus.

  • Who are Mirexus’s competitors?

    Ezaki Glico is a competitor of Mirexus.

  • When was Mirexus acquired?

    Mirexus was acquired on 15-Feb-2023.

  • Who acquired Mirexus?

    Mirexus was acquired by Mibelle Biochemistry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process